Concord Wealth Partners’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,500
| Closed | -$2K | – | 692 |
|
|
2022
Q2 | $2K | Hold |
1,500
| – | – | ﹤0.01% | 1033 |
|
|
2022
Q1 | $2K | Hold |
1,500
| – | – | ﹤0.01% | 1105 |
|
|
2021
Q4 | $4K | Hold |
1,500
| – | – | ﹤0.01% | 996 |
|
|
2021
Q3 | $4K | Hold |
1,500
| – | – | ﹤0.01% | 631 |
|
|
2021
Q2 | $4K | Hold |
1,500
| – | – | ﹤0.01% | 768 |
|
|
2021
Q1 | $4K | Buy |
+1,500
| New | +$4K | ﹤0.01% | 720 |
|